Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men.
SOX2 drives progression and therapy resistance in advanced prostate cancer
- Post author:admin
- Post published:
- Post category:uncategorized
Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men.